Overall Technical outlook

Price Summary

On 2025-07-16, Concord Biotech Limited's stock opened at 1838.5, reached 1868.0, hit a low of 1822.1, and rose 0.01% to close at 1838.6, with 241621 shares traded.
Over the past 52 weeks, the stock reached a maximum price of 2601.1 and a minimum price of 1386.7.
As per recommendations from 5 analysts, CONCORDBIO's future price is expected to span between 1700.0 and 2120.0, with a mean price around 1937.0.

Technicals

Support and Resistance: At 1838.6, the price is held up by support at 1747.45 and faces resistance at 2043.2 for CONCORDBIO. This suggests a trading range where 1747.45 provides a base and 2043.2 limits upward movement.
CONCORDBIO supportResistance 63b332
Support/Resistance for CONCORDBIO


Aroon: The AROON is in a neutral stance for CONCORDBIO, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
CONCORDBIO aroon 63b332
Aroon chart for Concord Biotech Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
CONCORDBIO bbands 63b332
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR remains bullish, reinforcing a significant support level. This steady support suggests that the market's upward trend may continue, providing a solid foundation for potential gains for CONCORDBIO. Investors might see this as an opportunity to capitalize on the ongoing bullish sentiment.
CONCORDBIO psar 63b332
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
CONCORDBIO stoch 63b332
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
CONCORDBIO trippleSMA 63b332
Tripple SMA chart for Concord Biotech Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.